• Product NameHaloperidol
• Brief DescriptionInhibitors
• Purification99.51%
• Biological ActivityHaloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function. Besides, Haloperidol has shown about 50-fold potency than chiorpromazine, the other antipsychotic drug. Haloperidol has shown beneficial effects in the treatment of delusions and hallucinations. These effects are mainly achieved through blockage of dopamine receptors in the mesocortex and limbic system.
• Target Name5-HT Receptor antagonist; Dopamine Receptor antagonist
• CAS No. 52-86-8
• Calculated MW 375.87
• Formulation C21H23ClFNO2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1
  Pathways:GPCR/G Protein; Neuroscience
  Receptor:5-HT; Dopamine
  Boling pt:529C
  Melting pt:152C
  Solubility:Ethanol: 8 mg/mL (21.28 mM); DMSO: 75 mg/mL (199.54 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Cai G, et al. Mol Pharmacol. 1999 Nov;56(5):989-96.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting